Racial disparities in characteristics and outcomes of patients undergoing mitral transcatheter edge-to-edge repair
暂无分享,去创建一个
R. Siegel | T. Chakravarty | Moody Makar | R. Makkar | O. Koren | A. Shechter | K. Koseki | V. Patel | D. Kaewkes | S. Skaf | Aum Solanki | Takashi Nagasaka | Manvir Dhillon
[1] Jeroen J. Bax,et al. Outcomes After Transcatheter Edge-to-Edge Mitral Valve Repair According to Mitral Regurgitation Etiology and Cardiac Remodeling. , 2022, JACC. Cardiovascular interventions.
[2] J. Pankow,et al. Racial and Ethnic Differences in All-Cause and Cardiovascular Disease Mortality: The MESA Study , 2022, Circulation.
[3] Robert M. Minutello,et al. Racial Disparities in Access to High-Volume Mitral Valve Transcatheter Edge-to-Edge Repair Centers , 2022, Journal of the Society for Cardiovascular Angiography & Interventions.
[4] A. Regueiro,et al. A Score to Assess Mortality After Percutaneous Mitral Valve Repair. , 2022, Journal of the American College of Cardiology.
[5] L. Sposato,et al. Racial, ethnic and socioeconomic disparities in patients undergoing transcatheter mitral edge-to-edge repair. , 2021, International journal of cardiology.
[6] B. Prendergast,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.
[7] Harjit Singh,et al. Trends, Predictors and In-Hospital Outcomes of the Next Day Discharge Approach After Transcatheter Mitral Valve Repair. , 2021, American Journal of Cardiology.
[8] P. Denti,et al. Implantation of one, two or multiple MitraClips for transcatheter mitral valve repair: insights from a 1824-patient multicenter study. , 2021, Panminerva Medica (Testo stampato).
[9] S. Solomon,et al. Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care , 2021, Heart.
[10] L. Sposato,et al. Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure , 2021, Heart.
[11] P. Denti,et al. Italian Society of Interventional Cardiology (GIse) registry Of Transcatheter treatment of mitral valve regurgitaTiOn (GIOTTO): impact of valve disease aetiology and residual mitral regurgitation after MitraClip implantation , 2021, European journal of heart failure.
[12] M. Mack,et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Circulation.
[13] S. Lirette,et al. Racial and Sex Differences in the Response to First-Line Antihypertensive Therapy , 2020, Frontiers in Cardiovascular Medicine.
[14] M. Mack,et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.
[15] G. Lloyd,et al. Racial Differences In the Aetiology of Mitral Valve Disease. , 2020, European heart journal. Quality of care & clinical outcomes.
[16] H. Jneid,et al. Racial disparities in the utilization and outcomes of transcatheter mitral valve repair: Insights from a national database. , 2020, Cardiovascular revascularization medicine : including molecular interventions.
[17] D. Holmes,et al. Racial Disparities in the Utilization and Outcomes of Structural Heart Disease Interventions in the United States , 2019, Journal of the American Heart Association.
[18] J. Carroll,et al. Racial Disparities in the Utilization and Outcomes of TAVR: TVT Registry Report. , 2019, JACC. Cardiovascular interventions.
[19] N. Weissman,et al. Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Socie , 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[20] M. Mack,et al. Transcatheter Mitral‐Valve Repair in Patients with Heart Failure , 2018, The New England journal of medicine.
[21] J. Spence,et al. Hypertension in Blacks: Individualized Therapy Based on Renin/Aldosterone Phenotyping , 2018, Hypertension.
[22] C. Denson. The MESA Study. , 2017 .
[23] Yuchi Han,et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[24] M. Mack,et al. Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II. , 2015, Journal of the American College of Cardiology.
[25] G. Filippatos,et al. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium. , 2015, Journal of the American College of Cardiology.
[26] Keith C. Norris,et al. African Americans, hypertension and the renin angiotensin system. , 2014, World journal of cardiology.
[27] Jean-Louis Vanoverschelde,et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[28] Saibal Kar,et al. Percutaneous repair or surgery for mitral regurgitation. , 2011, The New England journal of medicine.
[29] A. Galloway,et al. Mitral valve disease presentation and surgical outcome in African-American patients compared with white patients. , 2008, The Annals of thoracic surgery.